169 related articles for article (PubMed ID: 9126809)
1. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.
Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E
J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
5. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.
Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL
Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407
[TBL] [Abstract][Full Text] [Related]
7. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus lymphoproliferative disease of donor origin after kidney transplantation: a case report.
Renoult E; Aymard B; Grégoire MJ; Bellou A; Hubert J; Hestin D; Audouin J; Lederlin P; Kessler M
Am J Kidney Dis; 1995 Jul; 26(1):84-7. PubMed ID: 7611274
[TBL] [Abstract][Full Text] [Related]
9. Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.
Randhawa PS; Zeevi A; Alvares C; Gollin S; Agostini R; Yunis E; Saidman S; Contis L; Demetris AJ; Nalesnik MA
In Vitro Cell Dev Biol Anim; 1994 Jun; 30A(6):400-6. PubMed ID: 8087305
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients.
Sokal EM; Caragiozoglou T; Lamy M; Reding R; Otte JB
Transplantation; 1993 Dec; 56(6):1394-8. PubMed ID: 8279009
[TBL] [Abstract][Full Text] [Related]
11. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
12. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
McDiarmid SV; Jordan S; Kim GS; Toyoda M; Goss JA; Vargas JH; Martín MG; Bahar R; Maxfield AL; Ament ME; Busuttil RW
Transplantation; 1998 Dec; 66(12):1604-11. PubMed ID: 9884246
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated leiomyosarcomas in liver transplantation recipients. Origin from either donor or recipient tissue.
Timmons CF; Dawson DB; Richards CS; Andrews WS; Katz JA
Cancer; 1995 Oct; 76(8):1481-9. PubMed ID: 8620427
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: three-year experience.
Rogers BB; Sommerauer J; Quan A; Timmons CF; Dawson DB; Scheuermann RH; Krisher K; Atkins C
Pediatr Dev Pathol; 1998; 1(6):480-6. PubMed ID: 9724334
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
Hauke RJ; Greiner TC; Smir BN; Vose JM; Tarantolo SR; Bashir RM; Bierman PJ
Bone Marrow Transplant; 1998 Jun; 21(12):1271-4. PubMed ID: 9674863
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients.
Wu TT; Swerdlow SH; Locker J; Bahler D; Randhawa P; Yunis EJ; Dickman PS; Nalesnik MA
Hum Pathol; 1996 Feb; 27(2):157-64. PubMed ID: 8617457
[TBL] [Abstract][Full Text] [Related]
18. Aggressive Epstein-Barr virus-negative B-cell post-transplant lymphoproliferative disorder in a hepatitis C-negative liver transplant recipient who received a hepatitis C-positive graft: Implications for D+/R- hepatitis C virus seroconversion.
Kutzler HL; Collins K; Maneckshana B; Rochon C; Einstein M; Mnayer L; Rezuke WN; Sheiner P; Serrano OK
Transpl Infect Dis; 2019 Oct; 21(5):e13144. PubMed ID: 31291501
[TBL] [Abstract][Full Text] [Related]
19. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
20. Virus-specific cytotoxic T lymphocytes as prophylaxis for Epstein-Barr virus lymphoproliferative disease in pediatric bone marrow transplant recipients.
Norville R; Nance D; Cheshire S
J Pediatr Oncol Nurs; 1997 Oct; 14(4):194-201. PubMed ID: 9322393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]